Looking into the Q1 report, PDZ stated cash in hand of 728k. Net operating CF was -3.461 Mio (cash burn) for Q1. Any delay could be related to manage cash and it propably explains the steep decline in share price.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025